NOMDEDEU GUINOT, JOSEP FRANCESC FGS
jnomdedeu@santpau.cat
Sarda Vidal, Maria Pilar FGS
Ubeda Rodenas, Jose FGS
Martinez Valverde, Clara Maria FGS
Ortin Quilez, Rosa FGS
Martinez Sanchez, Elisabeth FGS
Espadaler Pare, Montserrat FGS
Estivill Riezu, Maria Camino FGS
Bussaglia Petrillo, Elena Mart FGS
Fuentes Hernandez, Francisca FGS
Carricondo Morcillo, Maite FGS
Hernandez Campos, Carmen FGS
Remacha Sevilla, Angel Francisco FGS
Fernandez Rosales, Maria Nieves FGS
Serra Ferrer, Marta FGS
Rubio Olmos, Miguel Angel IR
Blanco , Maria Laura FGS
Pratcorona Canela, Marta FGS
Bussaglia E., Anton R., Nomdedeu J.F., Fuentes-Prior P. (2019) TET2 missense variants in human neoplasia. A proposal of structural and functional classification. MOL GENET GENOM MED, 7 (7), -.
IF: 1,9950
de la Guardia R.D., Lopez-Millan B., Roca-Ho H., Bueno C., Gutierrez-Aguera F., Fuster J.L., Anguita E., Zanetti S.R., Vives S., Nomdedeu J., Sackstein R., Lavoie J., Gonzalez-Rey E., Delgado M., Rosu-Myles M., Menendez P. (2019) Bone marrow mesenchymal stem/stromal cells from risk-stratified acute myeloid leukemia patients are anti-inflammatory in in vivo preclinical models of hematopoietic reconstitution and severe colitis. HAEMATOLOGICA, 104 (2), e54-e58.
IF: 7,1160
Monter A., Nomdedeu J.F. (2019) ClonoSEQ assay for the detection of lymphoid malignancies. EXPERT REV MOL DIAGN, 19 (7), 571-578.
IF: 4,0960
Mora A., Bosch R., Cuellar C., Vicente E.P., Blanco L., Martino R., Ubeda J.M., Sierra J., Moreno C., Nomdedeu J. (2019) CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. CYTOM PART B-CLIN CY, 96 (2), 143-148.
IF: 2,0700
Onecha E., Linares M., Rapado I., Ruiz-Heredia Y., Martinez-Sanchez P., Cedena T., Pratcorona M., Oteyza J.P., Herrera P., Barragan E., Montesinos P., Vela J.A.G., Magro E., Anguita E., Figuera A., Riaza R., Martinez-Barranco P., Sanchez-Vega B., Nomdedeu J., Gallardo M., Martinez-Lopez J., Ayala R. (2019) A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia. HAEMATOLOGICA, 104 (2), 288-296.
IF: 7,1160
Ribera J., Granada I., Morgades M., Vives S., Genesca E., Gonzalez C., Nomdedeu J., Escoda L., Montesinos P., Mercadal S., Coll R., Gonzalez-Campos J., Abella E., Barba P., Bermudez A., Gil C., Tormo M., Pedreno M., Martinez-Carballeira D., Hernandez-Rivas J.-M., Orfao A., Martinez-Lopez J., Esteve J., Bravo P., Garcia-Guinon A., Deben G., Moraleda J.M., Quiezan J.A., Ortin X., Moreno M.J., Feliu E., Sole F., Ribera J.M. (2019) The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients. BRIT J HAEMATOL, 186 (2), 263-268.
IF: 5,5180
Ribera J., Zamora L., Morgades M., Vives S., Granada I., Montesinos P., Gomez-Segui I., Mercadal S., Guardia R., Nomdedeu J., Pratcorona M., Tormo M., Martinez-Lopez J., Hernandez-Rivas J.-M., Ciudad J., Orfao A., Gonzalez-Campos J., Barba P., Escoda L., Esteve J., Genesca E., Sole F., Feliu E., Ribera J.-M. (2019) Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia. GENE CHROMOSOME CANC, 58 (11), 815-819.
IF: 3,4440
Santaliestra M., Garrido A., Carricondo M., Bussaglia E., Pratcorona M., Blanco M.L., Gich I., Hoyos M., Esquirol A., Garcia-Cadenas I., Brunet S., Martino R., Sierra J., Nomdedeu J.F. (2019) Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5-azacytidine: Identification of responding patients. EUR J HAEMATOL, 103 (3), 208-214.
IF: 2,2200
Sobas M., Montesinos P., Boluda B., Bernal T., Vellenga E., Nomdedeu J., Gonzalez-Campos J., Chillon M., Holowiecka A., Esteve J., Bergua J., Gonzalez-Sanmiguel J.D., Gil-Cortes C., Tormo M., Salamero O., Manso F., Fernandez I., de la Serna J., Moreno M.-J., Perez-Encinas M., Krsnik I., Ribera J.-M., Escoda L., Lowenberg B., Sanz M.A. (2019) An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens. LEUKEMIA LYMPHOMA, 60 (4), 1030-1035.
IF: 2,9690
Genesca E., Lazarenkov A., Morgades M., Berbis G., Ruiz-Xiville N., Gomez-Marzo P., Ribera J., Junca J., Gonzalez-Perez A., Mercadal S., Guardia R., Artola M.T., Moreno M.J., Martinez-Lopez J., Zamora L., Barba P., Gil C., Tormo M., Cladera A., Novo A., Pratcorona M., Nomdedeu J., Gonzalez-Campos J., Almeida M., Cervera J., Montesinos P., Batlle M., Vives S., Esteve J., Feliu E., Sole F., Orfao A., Ribera J.M. (2018) Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia. J HEMATOL ONCOL, 11 (1), -.
IF: 8,7310
Guillem V., Calabuig M., Brunet S., Esteve J., Escoda L., Gallardo D., Ribera J.-M., Queipo de Llano M.P., Arnan M., Pedro C., Amigo M.L., Marti-Tutusaus J.M., Garcia-Guinon A., Bargay J., Sampol A., Salamero O., Font L., Talarn C., Hoyos M., Diaz-Beya M., Garrido A., Navarro B., Nomdedeu J., Sierra J., Tormo M. (2018) Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival. LEUKEMIA LYMPHOMA, 59 (10), 2383-2393.
IF: 2,6740
Martinez-Pedrero F., Tajuelo J., Sanchez-Puga P., Chulia-Jordan R., Ortega F., Rubio M.A., Rubio R.G. (2018) Linear shear rheological of aging β-casein films adsorbing at the air/water interface. J COLLOID INTERF SCI, 511 (), 12-20.
IF: 6,3610
Nomdedeu J.F., Esquirol A., Carricondo M., Pratcorona M., Hoyos M., Garrido A., Rubio M., Bussaglia E., Garcia-Cadenas I., Estivill C., Brunet S., Martino R., Sierra J. (2018) Bone Marrow WT1 Levels in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplasia: Clinically Relevant Time Points and 100 Copies Threshold Value. BIOL BLOOD MARROW TR, 24 (1), 55-63.
IF: 3,5990
Pallares V., Hoyos M., Chillon M.C., Barragan E., Conde M.I.P., Llop M., Falgas A., Cespedes M.V., Montesinos P., Nomdedeu J.F., Brunet S., Sanz M.A., Gonzalez-Diaz M., Sierra J., Mangues R., Casanova I. (2018) Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia. CANCERS, 10 (11), -.
IF: 6,1620
Rawstron A.C., Kreuzer K.-A., Soosapilla A., Spacek M., Stehlikova O., Gambell P., Mciver-Brown N., Villamor N., Psarra K., Arroz M., Milani R., de la Serna J., Cedena M.T., Jaksic O., Nomdedeu J., Moreno C., Rigolin G.M., Cuneo A., Johansen P., Johnsen H.E., Rosenquist R., Niemann C.U., Kern W., Westerman D., Trneny M., Mulligan S., Doubek M., Pospisilova S., Hillmen P., Oscier D., Hallek M., Ghia P., Montserrat E. (2018) Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. CYTOM PART B-CLIN CY, 94 (1), 121-128.
IF: 2,9380
Torrebadell M., Diaz-Beya M., Kalko S.G., Pratcorona M., Nomdedeu J., Navarro A., Gel B., Brunet S., Sierra J., Camos M., Esteve J. (2018) A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia. LEUKEMIA LYMPHOMA, 59 (10), 2394-2404.
IF: 2,6740
Vazquez-Santiago M., Vilalta N., Cuevas B., Murillo J., Llobet D., Macho R., Pujol-Moix N., Carrasco M., Mateo J., Fontcuberta J., Soria J.M., Souto J.C. (2018) Short closure time values in PFA–100® are related to venous thrombotic risk. Results from the RETROVE Study. THROMB RES, 169 (), 57-63.
IF: 3,2660
Vicente E.P., Cuellar-Garcia C., Martinez M., Soler A., Mora A., Bosch R., Brunet S., Briones J., Garcia I., Esquirol A., Granell M., Saavedra S., Nomdedeu J., Sierra J., Martino R., Moreno C. (2018) Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to Therapy. CL LYMPH MYELOM LEUK, 18 (11), 737-742.
IF: 2,2740